Cargando…
P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431289/ http://dx.doi.org/10.1097/01.HS9.0000846656.55700.df |
| _version_ | 1784780013452656640 |
|---|---|
| author | Rifkin, R. M. Costello, C. L. Birhiray, R. E. Kambhampati, S. Richter, J. Abonour, R. Lee, H. C. Kim, Y. J. Ren, K. Stull, D. M. Cherepanov, D. Bogard, K. Noga, S. J. Girnius, S. |
| author_facet | Rifkin, R. M. Costello, C. L. Birhiray, R. E. Kambhampati, S. Richter, J. Abonour, R. Lee, H. C. Kim, Y. J. Ren, K. Stull, D. M. Cherepanov, D. Bogard, K. Noga, S. J. Girnius, S. |
| author_sort | Rifkin, R. M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431289 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94312892022-08-31 P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) Rifkin, R. M. Costello, C. L. Birhiray, R. E. Kambhampati, S. Richter, J. Abonour, R. Lee, H. C. Kim, Y. J. Ren, K. Stull, D. M. Cherepanov, D. Bogard, K. Noga, S. J. Girnius, S. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431289/ http://dx.doi.org/10.1097/01.HS9.0000846656.55700.df Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Rifkin, R. M. Costello, C. L. Birhiray, R. E. Kambhampati, S. Richter, J. Abonour, R. Lee, H. C. Kim, Y. J. Ren, K. Stull, D. M. Cherepanov, D. Bogard, K. Noga, S. J. Girnius, S. P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_full | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_fullStr | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_full_unstemmed | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_short | P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) |
| title_sort | p947: comparative effectiveness of oral ixazomib-lenalidomide-dexamethasone (ird) after initial bortezomib (v)-based induction vs parenteral v-based therapy in newly diagnosed multiple myeloma (ndmm) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431289/ http://dx.doi.org/10.1097/01.HS9.0000846656.55700.df |
| work_keys_str_mv | AT rifkinrm p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT costellocl p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT birhirayre p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT kambhampatis p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT richterj p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT abonourr p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT leehc p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT kimyj p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT renk p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT stulldm p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT cherepanovd p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT bogardk p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT nogasj p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm AT girniuss p947comparativeeffectivenessoforalixazomiblenalidomidedexamethasoneirdafterinitialbortezomibvbasedinductionvsparenteralvbasedtherapyinnewlydiagnosedmultiplemyelomandmm |